pre-seed
Stage
About
Kindlingbio develops targeted gene therapies for childhood cancers by harnessing the unique biology of children's immune systems to create safe and effective immunotherapies distinct from those used in adults.
Explore Kindlingbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.